Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-01-01 @ 11:48 PM
Study NCT ID:
NCT06824103
Status:
RECRUITING
Last Update Posted:
2025-11-26
First Post:
2025-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2029-11-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-01-11
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-04
First Submit QC Date:
None
Study First Post Date:
2025-02-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-24
Last Update Post Date:
2025-11-26
Last Update Post Date Type:
ESTIMATED